Inquire About a Product| Product: | Pramipexole(Methyl-d3) DiHCl | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D2109 | ||||||||
| Synonyms: |
(S)-Pramipexole-d3, Dihydrochloride; (S)-4,5,6,7-Tetrahydro-N6-(propyl-d3)-2,6-benzothiazolediamine Dihydrochloride |
||||||||
| Pricing: |
|
||||||||
| Formula: | C10H16D3Cl2N3S | ||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 287.27 | ||||||||
| Structure: |
|
||||||||
| Appearance: | White solid | ||||||||
| Category: | Research Compounds | ||||||||
| Stability: | Stable under recommended storage conditions | ||||||||
| Storage: |
Keep container tightly closed in a dry and well-ventilated place. Store at -20°C under inert atmosphere |
||||||||
| Transportation: |
Non-hazardous for transport |
||||||||
| Literature References: |
Kvernmo T, Härtter S, Burger E., A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical Therapeutics, 2006, 28 (8): 1065–78.; Newman-Tancredi A, Cussac D, Audinot V, et al., Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor. The Journal of Pharmacology and Experimental Therapeutics, 2002, 303 (2): 805–14. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled dopamine agonist. Used to treat Parkinson's disease and restless leg syndrome. |